Max Financial Services Board Approves Rs. 389 Crore Equity Share Issuance by Axis Max Life to Axis Bank
Max Financial Services Limited announced that Axis Max Life Insurance Limited's board has approved a Rs. 389 crore equity share issuance to Axis Bank Limited. The transaction involves 2,50,56,200 shares at Rs. 151.90 per share through preferential allotment. Post-completion, Axis Bank and affiliates will hold 19.99% while Max Financial Services retains ~80.01% of Axis Max Life. The capital infusion, subject to shareholder approval, aims to support future growth initiatives.

*this image is generated using AI for illustrative purposes only.
Max Financial Services Limited has disclosed that the Board of Directors of Axis Max Life Insurance Limited has approved a significant capital infusion proposal. The board considered raising funds through the issuance of equity shares to Axis Bank Limited for an aggregate investment of up to Rs. 389 crores.
Transaction Details
The proposed equity issuance involves specific financial parameters and shareholding arrangements. Axis Max Life will issue equity shares of Rs. 10 each to Axis Bank Limited, with the transaction structured as a preferential allotment in accordance with applicable laws including Sections 42 and 62 of the Companies Act, 2013.
| Parameter | Details |
|---|---|
| Total Shares to be Issued | 2,50,56,200 equity shares |
| Face Value per Share | Rs. 10.00 |
| Issue Price per Share | Rs. 151.90 |
| Share Premium | Rs. 141.90 per share |
| Total Investment Amount | Rs. 389 crores |
| Valuation Method | Discounted cash flow method |
Shareholding Structure Post-Transaction
Upon completion of the proposed infusion, the shareholding pattern of Axis Max Life will undergo changes. Axis Bank, along with Axis Capital Limited and Axis Securities Limited, will collectively hold 19.99% of the equity share capital, while Max Financial Services Limited's shareholding will be approximately 80.01%.
| Entity | Pre-Issue Shares | Pre-Issue % | Shares to be Allotted | Post-Issue Shares | Post-Issue % |
|---|---|---|---|---|---|
| Axis Bank Limited | 33,44,60,446 | 16.22% | 2,50,56,200 | 35,95,16,646 | 17.23% |
| Axis Capital Limited | 3,83,76,257 | 1.86% | Nil | 3,83,76,257 | 1.84% |
| Axis Securities Limited | 1,91,88,128 | 0.94% | Nil | 1,91,88,128 | 0.92% |
| Total Axis Entities | 39,20,24,831 | 19.02% | 2,50,56,200 | 41,70,81,031 | 19.99% |
Regulatory and Strategic Context
The transaction aligns with existing agreements among the company stakeholders, including Max Financial Services Limited, Axis Bank, and other shareholders. Under these agreements, Axis Shareholders have the right to purchase equity shares equivalent to 0.98% of Axis Max Life's equity share capital to maintain their holding up to 19.99%. Axis Bank has received the requisite approval from the Reserve Bank of India for this capital infusion.
Approvals and Next Steps
The proposed infusion is subject to approval from the shareholders of Axis Max Life and all other necessary corporate approvals. The fair market value of the shares has been determined by Registered Valuers and Category 1 Merchant Bankers using the discounted cash flow method as per extant regulations. This capital infusion will help Axis Max Life meet its funding requirements to support future growth initiatives.
Historical Stock Returns for Max Financial Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.89% | -7.67% | -19.26% | -9.72% | +28.24% | +66.33% |
How will this Rs. 389 crore capital infusion impact Axis Max Life's competitive positioning in India's rapidly growing life insurance market?
What specific growth initiatives and expansion plans does Axis Max Life intend to pursue with the additional funding?
Could this transaction signal potential future consolidation moves between Axis Bank and Max Financial Services beyond the current 19.99% threshold?


































